MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. KBH
2. PATH
3. SPY
4. USO
5. AZO
6. RCL
7. ORCL
8. ONON
9. PLTR
10. PRGS

Go back to MacroGenics Earns $60 Million Milestone with U.S. FDA Approval of Teplizumab
MACROGENICS (NASDAQ: MGNX) Delayed: 3.90 -0.22 (5.34%)
Previous Close $4.12    52 Week High $36.11 
Open $4.12    52 Week Low $14.84 
Day High $4.12    P/E 10.00 
Day Low $3.88    EPS $0.39 
Volume 145,119